News

Article by Andrew Kimball: Business Development for Research Sites

March 30, 2020

Andrew Kimball, vice president, business development (BD), recently published an article in SCRS InSite that highlights the importance of BD at research sites and networks. The article outlines BD’s role in enhancing feasibility processes, opportunity sourcing, and the nurturing of long-term partnerships with Sponsors and CROs. đź“° Full article: https://cloud.3dissue.com/180561/181052/211361/SpringInsite2020/index.html?page=6

Meridian Continues to Support Trials at Sites Nationwide, Will Remain Operational Amid COVID-19 Pandemic

March 24, 2020

Meridian Clinical Research, a leading investigative research network, will remain open to support the research of investigational tests, vaccines, and medications intended for commercial release. Meridian sites are working with Sponsors and contract research organizations (CROs) to ensure patient safety while continuing to enroll patients during the COVID-19 pandemic. The company has enrolled more than 25,000 subjects into vaccine and infectious disease clinical trials in the past 20 years. Nicole Osborn, CEO, says Meridian has always focused on protecting healthy participants and patients with acute conditions. “We’re fully prepared to address any COVID-19 opportunity and support novel research and development … Read more

Meridian Clinical Research is a Finalist for Two Vaccine Industry Excellence (ViE) Awards, Expects Elevated Demand for Vaccine Trials in 2020

February 27, 2020

Meridian Clinical Research, a leading investigative research network, is a finalist to win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which is a finalist for the Best Clinical Trial Network award. These nominations were the result of two voting rounds, and winners will be announced at the World Vaccine Congress in Washington, D.C. in early April. The nomination comes as Meridian has experienced its largest ever year for vaccine and infectious disease study enrollment. “We’re the partner of choice for many high-volume and specialized vaccine … Read more

Meridian Donates More Than $290,000 in 2019 as Part of Employee Performance Program

December 17, 2019

Omaha, Neb., December 17, 2019 — Meridian Clinical Research, a leading investigative research network, has donated more than $290,000 to people in need, fundraisers, and charitable organizations in 2019. The amount was accumulated through a novel employee incentive program that intertwines annual bonus and charitable giving budgets. “Our communities and our patients are at the forefront of everything we do,” said Nicole Osborn, Meridian founder and CEO. “This year we launched the All In: Strength in Numbers program to help more people beyond the clinic. We set what we thought was an ambitious goal of $209,700. The team reached more … Read more

Three Meridian Principal Investigators Win Best of Savannah Doctors 2019 Award

November 18, 2019

Three Meridian principal investigators were voted Best of Savannah Doctors 2019 by Savannah Magazine readers. The award winners include: Buffi G. Boyd, MD, of Urological Associates of Savannah, PC for Best Urologist Corinne Howington, MD, of Low Country Dermatology for Best Dermatologist Michael Hemphill, MD, of Savannah Neurology Specialists for Best Neurologist Read Savannah Magazine’s Best of Savannah Doctors 2019: https://issuu.com/savannahmagazine/docs/2019_best_of_doctors

Meridian Clinical Research Celebrates 20 Years, Holds its Largest Ever Annual Physician Meeting

August 1, 2019

Meridian Clinical Research, a leading investigative research network, is celebrating its twentieth year in business. Meridian was founded by Nicole Osborn, the company’s CEO, in 1999. It began as a single research site in Omaha, Neb., where the company is headquartered. Meridian added locations in Norfolk, Neb., and Dakota Dunes, S.D., before establishing a strong presence in Savannah, Ga., where five of its research sites are located. More sites are located in Baton Rouge, La., Rockville, Md., Norfolk, Va., and Mexico. Meridian recently acquired Regional Clinical Research, which operates four investigative research sites in the southern tier of New York. … Read more

Meridian Clinical Research Acquires Regional Clinical Research of New York

July 22, 2019

Meridian Clinical Research, LLC, based in Omaha, NE, has acquired the assets and operations of Regional Clinical Research, Inc., expanding its North American footprint to more than 20 investigative sites. Regional was established in 1993 by Bruce Bowling, MD, and Victor Elinoff, MD, and operates four research sites in the southern tier of New York. Meridian and Regional are longtime members of Platinum Research Network. The acquisition enhances Meridian’s existing therapeutic expertise in infectious diseases, neurology, and women’s health. “This is a perfect addition,” said Nicole Osborn, founder and CEO of Meridian. “We’ve known Regional’s leaders and collaborated on best … Read more

Bounphone “Willow” Chanthavong, MPH, CCRC is the 2019 PharmaTimes Clinical Research Coordinator of the Year

May 6, 2019

Bounphone Chanthavong (Willow), MPH, CCRC, is your 2019 PharmaTimes Clinical Research Coordinator of the Year! Willow is a research coordinator at Meridian’s neurology site in Savannah, Ga., and won the award on May 4, 2019, after a three-stage competition involving an initial online test, a written essay challenge, and an in-person presentation in Boston. This is an outstanding honor for an outstanding teammate — Willow has managed to set the bar even higher for Meridian. Congratulations, Willow! Meridian also congratulates Mercedes Livingston at Ventavia Research Group (a Platinum Research Network member) on winning silver in the competition. Well done and … Read more

Platinum Research Network Recognized at the Vaccine Industry Excellence Awards

April 25, 2019

Platinum Research Network was named highly commended for the Best Clinical Site or Network category at the 2018/2019 Vaccine Industry Excellence (ViE) Awards. The award recognizes investigative site networks that support diverse clinical trials for vaccines, introduce novel services to improve performance, achieve rapid enrollment, and uphold high subject retention. — Meridian Clinical Research is the largest member of Platinum, which provides access to more than 47 million patients worldwide. In 2018, Meridian and Platinum strengthened strategic partnerships with vaccine developers, added several vaccine research sites to its network, and expanded clinical infrastructure and peripheral blood mononuclear cell (PBMC) processing … Read more

Savannah Plastic Surgery Partners With Meridian Clinical Research, Creates New Clinical Trial Opportunities in Savannah

April 24, 2019

Meridian Clinical Research and Savannah Plastic Surgery are partnering to conduct clinical trials in Savannah, Ga. Dr. Luke Curtsinger and Dr. Matthew McLeod at Savannah Plastic Surgery will serve as principal investigators and lead the conduct of research studies for novel surgical approaches, pharmaceutical products, and medical devices. “Clinical research makes progress possible,” said Dr. Curtsinger. “Conducting trials will enable us to offer expanded care options to our patients today, and will drive the development of next generation treatment approaches.” This will be Meridian’s sixth site located in Savannah, and its first plastic and cosmetic research site in North America. … Read more